|Articles|September 4, 2018

Pharmaceutical Commerce - September 2018
Volume 13
Issue 3

Cold Chain Suppliers Spotlight Directory

Download and read the Cold Chain Suppliers Spotlight Directory here.

Articles in this issue

over 7 years ago

Article

Gimme my data

over 7 years ago

Article

A Conversation with Rafik Bishara

over 7 years ago

Article

The 2018 Pharma Cold Chain: more data leads to less risk

over 7 years ago

Article

Biopharma cold-chain market forecast

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!

Related Content

Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics

ByNicholas Saraceno, Editor

December 4th 2025

Pharma Pulse: HHS Updates Menopausal Hormone Therapy Labels, as SGLT2 Inhibitors Show Broader Kidney and Heart Benefits

ByNicholas Saraceno, Editor

November 12th 2025

Arsenal Capital Partners Completes ThermoSafe Acquisition

ByNicholas Saraceno, Editor

November 11th 2025

Cencora Reveals $1 Billion Investment Plan Enhancing US-Based Distribution Network

ByNicholas Jacobus

November 5th 2025

LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control

ByNicholas Saraceno, Editor,Krenar Komoni,Ammie McAsey,Dave Malenfant

October 27th 2025

Cold Chain Suppliers Spotlight Directory

Articles in this issue

Newsletter

Related Content

Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics

Pharma Pulse: HHS Updates Menopausal Hormone Therapy Labels, as SGLT2 Inhibitors Show Broader Kidney and Heart Benefits

Arsenal Capital Partners Completes ThermoSafe Acquisition

Cencora Reveals $1 Billion Investment Plan Enhancing US-Based Distribution Network

LogiPharma USA 2025: Pharma Supply Chains Evolve Toward Real-Time Visibility and End-to-End Control

Trending on Pharmaceutical Commerce

Trade & Channel Strategies 2025: Channel Strategies Evolve, With Industry Leaders Pushing Toward Faster, More Connected Patient Access

Trade & Channel Strategies 2025: How Regulatory & Patent Cliff Disruption is Remaking Pharma Channels

Pharma Pulse: FDA Shifts CAR-T Standards and Maryland Expands Medical Class Size, as Pharma Channels Brace for Massive Patent Cliff Disruption

HTI-4 Standards Target Lack of Transparency in Medication Access

Pharma Pulse: Lilly’s Jaypirca Challenges Imbruvica, as AI Chatbots Could Prove Key to Boosting Vaccine Rates